SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-23-000031
Filing Date
2023-08-08
Accepted
2023-08-08 16:54:33
Documents
114
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-20230630.htm   iXBRL 10-Q 2057401
2 EX-10.1 amrx-2023063010xqexx101.htm EX-10.1 199230
3 EX-10.2 amrx-2023063010xqexx102.htm EX-10.2 51994
4 EX-10.3 amrx-2023063010xqexx103.htm EX-10.3 53826
5 EX-31.1 amrx-2023063010xqexx311.htm EX-31.1 10349
6 EX-31.2 amrx-2023063010xqexx312.htm EX-31.2 10266
7 EX-31.3 amrx-2023063010xqexx313.htm EX-31.3 10423
8 EX-32.1 amrx-2023063010xqexx321.htm EX-32.1 5619
9 EX-32.2 amrx-2023063010xqexx322.htm EX-32.2 5565
10 EX-32.3 amrx-2023063010xqexx323.htm EX-32.3 5654
16 image_0.jpg GRAPHIC 4835
  Complete submission text file 0001723128-23-000031.txt   11362840

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20230630.xsd EX-101.SCH 86651
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20230630_cal.xml EX-101.CAL 100727
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20230630_def.xml EX-101.DEF 409427
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20230630_lab.xml EX-101.LAB 921574
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20230630_pre.xml EX-101.PRE 618620
108 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20230630_htm.xml XML 1894677
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 231152263
SIC: 2834 Pharmaceutical Preparations